Oral Versus Intravenous Antibiotics for Bone and Joint Infections (OVIVA B&J) (OVIVA)
Randomized Open Label Study of Oral Versus Intravenous Antibiotic Treatment for Bone and Joint Infections Requiring Prolonged Antibiotic Treatment: Multi-centre Study
Sponsor: Oxford University Hospitals NHS Trust
This PHASE4 trial investigates Bone Infection and Joint Infection and is currently completed. Oxford University Hospitals NHS Trust leads this study, which shows 10 recorded versions since 2010 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 5 earlier versions
-
Jul 2020 — Jan 2021 [monthly]
Completed PHASE4
-
Jun 2018 — Jul 2020 [monthly]
Completed PHASE4
-
Dec 2017 — Jun 2018 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Feb 2017 — Dec 2017 [monthly]
Unknown Status PHASE4
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE4
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oxford University Hospitals NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .